Louise Bier

ORCID: 0000-0001-9692-5611
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genomics and Rare Diseases
  • Lysosomal Storage Disorders Research
  • Genetics and Neurodevelopmental Disorders
  • Cellular transport and secretion
  • BRCA gene mutations in cancer
  • Genomic variations and chromosomal abnormalities
  • Carbohydrate Chemistry and Synthesis
  • Autism Spectrum Disorder Research
  • Renal Diseases and Glomerulopathies
  • Erythrocyte Function and Pathophysiology
  • Ethics in Clinical Research
  • Cerebral Palsy and Movement Disorders
  • Epilepsy research and treatment
  • Congenital Anomalies and Fetal Surgery
  • Prenatal Screening and Diagnostics
  • Glycosylation and Glycoproteins Research
  • Pancreatic function and diabetes
  • Research Data Management Practices
  • Family and Disability Support Research
  • Chronic Lymphocytic Leukemia Research
  • Data Quality and Management
  • Genetic Syndromes and Imprinting
  • Studies on Chitinases and Chitosanases
  • Renal and related cancers
  • Scientific Computing and Data Management

Icahn School of Medicine at Mount Sinai
2012-2025

Columbia University Irving Medical Center
2016-2024

Columbia University
2016-2023

Synod Hospital
2021

Presbyterian Hospital
2021

Cincinnati Children's Hospital Medical Center
2014

Information on age-specific risk for Parkinson disease (PD) in patients with Gaucher (GD) and glucocerebrosidase (GBA) heterozygotes is important understanding the pathophysiology of genetic association counseling these populations.

10.1001/jamaneurol.2014.313 article EN JAMA Neurology 2014-04-21
Andrea H. Ramirez Lina Sulieman David J. Schlueter Alese E. Halvorson Jun Qian and 95 more Francis Ratsimbazafy Roxana Loperena Kelsey Mayo Melissa Basford Nicole Deflaux Karthik Muthuraman Karthik Natarajan Abel Kho Hua Xu Consuelo H. Wilkins Hoda Anton‐Culver Eric Boerwinkle Mine Cicek Cheryl R. Clark Ellen G. Cohn Lucila Ohno‐Machado Sheri D. Schully Brian K. Ahmedani Maria Argos Robert M. Cronin Christopher J. O’Donnell Mona N. Fouad David B. Goldstein Philip Greenland Scott J. Hebbring Elizabeth W. Karlson Parinda Khatri Bruce R. Korf Jordan W. Smoller Stephen Sodeke John Wilbanks Justin Hentges Stephen Mockrin Chris Lunt Stephanie A. Devaney Kelly A. Gebo Joshua C. Denny Robert J. Carroll David Glazer Paul A. Harris George Hripcsak Anthony Philippakis Dan M. Roden Brian K. Ahmedani Christine D. Cole Johnson Ahsan Habib Donna Antoine‐LaVigne Glendora Singleton Hoda Anton‐Culver Eric J. Topol Katie Baca-Motes Steven R. Steinhubl James B. Wade Mark Begale Praduman Jain Scott Sutherland Beth A. Lewis Bruce R. Korf Melissa Behringer Ali G. Gharavi David B. Goldstein George Hripcsak Louise Bier Eric Boerwinkle Murray H. Brilliant Narayana S. Murali Scott J. Hebbring Dorothy Farrar‐Edwards Elizabeth S. Burnside Marc K. Drezner Amy E. Taylor Veena Channamsetty Wanda Montalvo Yashoda Sharma Carmen Chinea Nancy Piper Jenks Mine Cicek S. N. Thibodeau Beverly Holmes Eric Schlueter Ever Collier Joyce Winkler John Corcoran Nick D’Addezio Martha L. Daviglus Robert A. Winn Consuelo H. Wilkins Dan M. Roden Joshua C. Denny Kim Doheny Debbie A. Nickerson Evan E. Eichler Gail P. Jarvik Gretchen Funk Anthony Philippakis

The

10.1016/j.patter.2022.100570 article EN cc-by-nc-nd Patterns 2022-08-01

Exome sequencing is increasingly being used for clinical diagnostics, with an impetus to expand reporting of incidental findings across a wide range disorders. Analysis population cohorts can help reduce risk genetic variant misclassification and resultant unnecessary referrals subspecialists.To examine the burden candidate pathogenic variants kidney genitourinary disorders emerging from exome sequencing.Secondary analysis data.A tertiary care academic medical center.A convenience sample...

10.7326/m18-1241 article EN Annals of Internal Medicine 2018-11-26

AIM To determine which patients with cerebral palsy (CP) should undergo genetic testing, we compared the rate of likely causative variants from whole-exome sequencing in individuals and without environmental risk factors. METHOD Patients were part a convenience physician-referred cohort recruited single medical center, research was completed. Participants evaluated for following factors: extreme preterm birth, brain bleed or stroke, birth asphyxia, malformations, intrauterine infection....

10.1111/dmcn.14948 article EN Developmental Medicine & Child Neurology 2021-06-10

NBEA is a candidate gene for autism, and de novo variants have been reported in neurodevelopmental disease (NDD) cohorts. However, has not rigorously evaluated as gene, associated phenotypes delineated. We identified 24 patients with NDD, establishing an NDD gene. Most had epilepsy onset the first few years of life, often characterized by generalized seizure types, including myoclonic atonic seizures. Our data show broader phenotypic spectrum than previously described, myoclonic‐astatic...

10.1002/ana.25350 article EN Annals of Neurology 2018-09-30

Abstract Genetic counseling for patients who are pursuing genetic testing in the absence of a medical indication, referred to as elective genomic (EGT), is becoming more common. This type has potential detect conditions before there significant health impact permitting earlier management and/or treatment. Pre‐ and post‐test EGT similar indication‐based testing. Both require complete family history when ordering test or interpreting result. However, some special considerations including...

10.1002/jgc4.1654 article EN Journal of Genetic Counseling 2023-01-04

Background Studies indicate that variants of uncertain significance are more common in non-European populations due to lack a diversity population databases. This difference has not been explored epilepsy, which is increasingly found be genetic paediatric populations, and precision medicine applications. study examines the differences frequency next-generation sequencing (NGS) results among epilepsy cohort between ancestral groups historically under-represented biomedical research (UBR)...

10.1136/jmg-2023-109450 article EN Journal of Medical Genetics 2024-03-07

CSNK2B has recently been implicated as a disease gene for neurodevelopmental disability (NDD) and epilepsy. Information about developmental outcomes limited by the young age short follow-up many of previously reported cases, further delineation spectrum associated phenotypes is needed. We present 25 new patients with variants in refine NDD epilepsy phenotypes. were identified research or clinical exome sequencing, investigators from different centers connected via GeneMatcher. Most...

10.1111/epi.16931 article EN Epilepsia 2021-05-26

The All of Us Research Program aims to return value participants by developing research capacity in communities. We describe a novel set introductory exercises (Data Sandboxes) and specialized trainings orient researchers the Researcher Workbench foster health equity research.

10.1093/jamia/ocae174 article EN Journal of the American Medical Informatics Association 2024-07-30

Gaucher disease (GD) is an autosomal recessive caused by GBA mutations that especially common in the Ashkenazi Jewish (AJ) population. The link between and Parkinson (PD), a later-onset neurodegenerative condition, well established, studies have shown carriers increased lifetime risk of developing PD. Carrier screening for GD frequently offered to couples during or prior pregnancy, those AJ descent. However, no been performed assess if prospective parents would want learn about their PD...

10.1007/s10897-017-0161-0 article EN Journal of Genetic Counseling 2017-09-29

The association between 1p32-p31 contiguous gene deletions and a distinct phenotype that includes anomalies of the corpus callosum, ventriculomegaly, developmental delay, seizures, dysmorphic features has been long recognized described. Recently, observation overlapping phenotypes in patients with chromosome translocations disrupt NFIA (Nuclear factor I/A), within this deleted region, intragenic led to hypothesis is critical region. wide application increasing accessibility whole exome...

10.1002/ajmg.a.38460 article EN American Journal of Medical Genetics Part A 2017-09-22
Coming Soon ...